[Introduction of an anticholinesterase drug in the context of myasthenia, in a severe asthmatic patient]

Rev Mal Respir. 2022 Jan;39(1):55-57. doi: 10.1016/j.rmr.2021.11.001. Epub 2021 Dec 2.
[Article in French]

Abstract

Association of asthma with myasthenia gravis presents a twofold peculiarity. First, as dyspnea characterizes both conditions, diagnostic orientation is difficult. Second, from a therapeutic standpoint, the initiation of anticholinesterase treatment requires a multidisciplinary approach due to possible contraindication for asthma. We report on the case of a patient monitored for severe asthma and treated with biotherapy, and also monitored for myasthenia gravis, and treated with anticholinesterase.

Keywords: Anticholinergic; Anticholinergique; Anticholinesterase; Anticholinestérasique; Asthme sévère; Severe asthma.

Publication types

  • Case Reports

MeSH terms

  • Asthma* / complications
  • Asthma* / drug therapy
  • Cholinesterase Inhibitors
  • Dyspnea
  • Humans
  • Hyperplasia
  • Myasthenia Gravis* / complications
  • Myasthenia Gravis* / diagnosis
  • Myasthenia Gravis* / drug therapy

Substances

  • Cholinesterase Inhibitors